Stock Analysts’ updated eps estimates for Tuesday, August 15th:

Advance Auto Parts (NYSE:AAP) had its hold rating reaffirmed by analysts at Oppenheimer Holdings, Inc..

Atlantic Capital Bancshares (NASDAQ:ACBI) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Atlantic Capital Bancshares, Inc. is a bank holding company. The Company’s corporate and business banking services include lending and financing, treasury services and international banking. Its private banking products and services include deposit products such as checking accounts, money market accounts, savings accounts and certificates of deposit; credit products include home equity lines of credit, secured personal lines of credit, unsecured lines of credit, home improvement loans, car loans and credit cards and services include online banking and bill payment, wire transfers, automated teller machine, eDelivery of statements and documents and person-to-person payments. Atlantic Capital Bancshares, Inc. is based in Atlanta, Georgia. “

Aercap Holdings N.V. (NYSE:AER) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $54.00 target price on the stock. According to Zacks, “AERCAP HOLDINGS is an integrated global aviation company with a leading market position in aircraft and engine leasing, trading and parts sales.They also provides aircraft management services and performs aircraft and engine maintenance, repair and overhaul services and aircraft disassemblies through its certified repair stations. “

Allot Communications (NASDAQ:ALLT) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Allot Communications Ltd. is a leading provider of intelligent IP service optimization solutions. Designed for carriers, service providers and enterprises, Allot solutions apply deep packet inspection technology to transform broadband pipes into smart networks. This creates the visibility and control vital to manage applications, services and subscribers, guarantee quality of service, contain operating costs and maximize revenue. Allot believes in listening to customers and provides them access to its global network of visionaries, innovators and support engineers. “

Alliqua BioMedical (NASDAQ:ALQA) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $0.50 target price on the stock. According to Zacks, “Alliqua, Inc. is a biomedical company. The company focused on the development, manufacturing and distribution of proprietary transdermal wound care and drug delivery technologies. Its technology platform produces hydrogels, a 3-dimensional cross-linked network of water soluble polymers. The company’s product includes SilverSeal(R) a hydrogel wound dressing with silver coated fibers and Hydress(R) an over-the-counter hydrogel wound dressing. It serves the healthcare industry including wound healing, medical diagnostics and cosmeceuticals. Alliqua, Inc. is headquartered in Langhorne, Pennsylvania. “

Absolute Software (NASDAQ:ALSWF) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $7.00 target price on the stock. According to Zacks, “Absolute Software Corporation engages in the business of providing firmware-persistent endpoint security and management solutions. It provides solutions for computer security monitoring and endpoint management industry. The company’s solutions include data protection, lifecycle management, enterprise mobility management and IT service management as well as data loss prevention. Absolute Software Corporation is headquartered in Vancouver, Canada. “

AnaptysBio (NASDAQ:ANAB) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $24.00 price target on the stock. According to Zacks, “AnaptysBio, Inc. is a biotechnology company. It involved in the discovery and development of therapeutic antibodies for inflammation and immuno-oncology primarily in the Unites states. AnaptysBio, Inc. is based in San Diego, California. “

Anthera Pharmaceuticals (NASDAQ:ANTH) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing products to treat serious illnesses, including cardiovascular and autoimmune diseases. The Company’s clinical-stage programs include one Phase 3 ready program, A-002, and two Phase 2 clinical programs, A-623 and A-001. A-002 and A-001 inhibit a novel enzyme target known as secretory phospholipase A2, or sPLA2. Elevated levels of sPLA2 have been implicated in a variety of acute inflammatory conditions, including acute coronary syndrome and acute chest syndrome, as well as chronic diseases such as stable coronary artery disease. A-623 targets elevated levels of B-lymphocyte stimulator, or BLyS (also known as BAFF), which has been associated with a variety of B-cell mediated autoimmune diseases, including systemic lupus erythematosus (SLE), rheumatoid arthritis, multiple sclerosis, Sj√∂gren’s Syndrome, Graves’ Disease and others. Anthera Pharmaceuticals, Inc. is headquartered in Hayward, California. “

Aquinox Pharmaceuticals (NASDAQ:AQXP) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company discovers and develops oral drug candidates to treat inflammation and cancer. Aquinox Pharmaceuticals, Inc. is headquartered in Vancouver, Canada. “

British American Tobacco p.l.c. (NYSE:BTI) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $70.00 target price on the stock. According to Zacks, “British American Tobacco is the holding company of a group of companies which manufacture, market and sell tobacco products. “

China Coal Energy Unspon (NASDAQ:CCOZY) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “China Coal Energy Company Limited is engaged in integrating engineering and technological service businesses comprising of coal production, sales and trading. It deals in coal chemical, coal mining equipment manufacturing, pit mouth power generation, coal mine design etc. The main businesses of the Company are coking operations, coal mining equipment manufacturing and coal mine design and consultation. Coal business involves in production and distribution of steam coal and coking coal. Coking business provides metallurgy coke and forging coke. Coke mining equipment business offers hydraulic supports, scraper conveyors, loaders, boring machines, shearers and mining electrical motors, among others. China Coal Energy Company Limited is headquartered in Beijing, China. “

Coach (NYSE:COH) was given a $55.00 target price by analysts at Oppenheimer Holdings, Inc.. The firm currently has a buy rating on the stock.

CSRA (NYSE:CSRA) had its buy rating reaffirmed by analysts at Royal Bank Of Canada.

Digital Ally (NASDAQ:DGLY) was given a $9.00 price target by analysts at Maxim Group. The firm currently has a buy rating on the stock.

Dick’s Sporting Goods (NYSE:DKS) was downgraded by analysts at Canaccord Genuity from a buy rating to a hold rating. They currently have $27.00 target price on the stock, down from their previous target price of $52.00.

Dick’s Sporting Goods (NYSE:DKS) was downgraded by analysts at Wedbush from an outperform rating to a neutral rating.

Dick’s Sporting Goods (NYSE:DKS) was downgraded by analysts at MKM Partners from a buy rating to a neutral rating.

Dick’s Sporting Goods (NYSE:DKS) was downgraded by analysts at Deutsche Bank AG from a buy rating to a hold rating.

Ford Motor (NYSE:F) had its buy rating reiterated by analysts at Royal Bank Of Canada.

Healthcare Realty Trust (NYSE:HR) had its buy rating reaffirmed by analysts at Cantor Fitzgerald. The firm currently has a $38.00 price target on the stock. The analysts wrote, “2017-18 Outlook. Our normalized FFO estimates are $1.60 per share in 2017 (unchanged) and $1.80 in 2018 (vs. prior $1.75). We are making limited changes to our normalized FFO estimates, despite last week’s equity offering, and estimate that the pending Atlanta deal could add $30 million of rent and push up 2018 a nickel relative to our former FFO estimate. Increased divestitures in 1H17 and the 4Q16 sale of three IRFs diluted 1Q17 FFO by $0.01 and 2Q17 by $0.02, but we expect the proceeds to be reinvested by the end of this year.””

Intercontinental Exchange (NYSE:ICE) had its buy rating reaffirmed by analysts at Royal Bank Of Canada.

Milestone Scientific (NASDAQ:MLSS) had its buy rating reissued by analysts at Maxim Group. They currently have a $4.00 price target on the stock.

Onconova Therapeutics (NASDAQ:ONTX) was given a $6.00 price target by analysts at Maxim Group. The firm currently has a buy rating on the stock.

Pacific Gas & Electric Co. (NYSE:PCG) had its buy rating reiterated by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a $70.00 price target on the stock.

Performance Food Group (NYSE:PFGC) was given a $27.00 price target by analysts at Royal Bank Of Canada. The firm currently has a hold rating on the stock.

Transocean (NYSE:RIG) was upgraded by analysts at Bank of America Corporation from an underperform rating to a neutral rating.

Time Warner (NYSE:TWX) had its hold rating reaffirmed by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a $108.00 price target on the stock.

UNITIL Corporation (NYSE:UTL) had its hold rating reiterated by analysts at Royal Bank Of Canada. They currently have a $47.00 target price on the stock.

Vmware (NYSE:VMW) had its buy rating reissued by analysts at Royal Bank Of Canada. The firm currently has a $113.00 target price on the stock.

Verint Systems (NASDAQ:VRNT) had its buy rating reiterated by analysts at Royal Bank Of Canada. They currently have a $48.00 target price on the stock.

ViaSat (NASDAQ:VSAT) was given a $50.00 target price by analysts at Royal Bank Of Canada. The firm currently has a sell rating on the stock.

Xplore Technologies Corp (NASDAQ:XPLR) was upgraded by analysts at Zacks Investment Research from a hold rating to a strong-buy rating. The firm currently has $2.50 price target on the stock. According to Zacks, “Xplore Technologies Corp. is engaged in the business of developing integrating and marketing mobile wireless Tablet PC computing systems. Its end-users are able to receive, collect, analyze, manipulate and transmit information in a variety of environments not suited to traditional non-rugged computing devices with the Company’s rugged computing products. The company’s portfolio of product is sold on a global basis. Xplore Technologies Corp. is headquartered in Austin, Texas. “

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.